PATH’s landmark research findings have dramatically impacted the way major medical conditions are addressed.
Among our accomplishments, we are proud to count:
• New breakthroughs in adult and childhood Attention Deficit Disorder
• Establishment of the best cornerstone for early detection of Alzheimer’s Disease
• Identification of the first gene associated with addiction
• Development and modernization of an improved method for selecting neuropsychiatric medication based on neurotransmitters and bioelectrical imbalances in the brain.
• Publicizing the inaccuracy of the BMI (body mass index) and the superiority of the DEXA scan as a measure of body fat and obesity
Dr. Braverman, MD has presented dozens of abstracts and published more than 130 papers which have appeared in peer-reviewed journals including Journal of Clinical Electroencephalography & Neuroscience, Molecular Psychiatry, and Nature. Noted scholars, clinicians, and scientists around the world have acknowledged the contributions of PATH researchers.
